374 related articles for article (PubMed ID: 33817766)
21. [Challenges in the differential diagnoses of parkinsonism].
Bech S; Haugbøl S; Winge K
Ugeskr Laeger; 2017 Aug; 179(33):. PubMed ID: 28869013
[TBL] [Abstract][Full Text] [Related]
22. Central auditory processing in parkinsonian disorders: A systematic review.
De Groote E; De Keyser K; Bockstael A; Botteldooren D; Santens P; De Letter M
Neurosci Biobehav Rev; 2020 Jun; 113():111-132. PubMed ID: 32145223
[TBL] [Abstract][Full Text] [Related]
23. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
24. Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients.
De Micco R; Agosta F; Basaia S; Siciliano M; Cividini C; Tedeschi G; Filippi M; Tessitore A
Mov Disord; 2021 Jul; 36(7):1603-1616. PubMed ID: 33639029
[TBL] [Abstract][Full Text] [Related]
25. Update on neuroimaging for categorization of Parkinson's disease and atypical parkinsonism.
Chougar L; Pyatigorskaya N; Lehéricy S
Curr Opin Neurol; 2021 Aug; 34(4):514-524. PubMed ID: 34010220
[TBL] [Abstract][Full Text] [Related]
26. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound.
Behnke S; Berg D; Naumann M; Becker G
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):423-5. PubMed ID: 15716540
[TBL] [Abstract][Full Text] [Related]
28. The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.
Gerstenecker A
Arch Clin Neuropsychol; 2017 Nov; 32(7):861-875. PubMed ID: 28961692
[TBL] [Abstract][Full Text] [Related]
29. Is Levodopa Response a Valid Indicator of Parkinson's Disease?
Martin WRW; Miles M; Zhong Q; Hartlein J; Racette BA; Norris SA; Ushe M; Maiti B; Criswell S; Davis AA; Kotzbauer PT; Cairns NJ; Perrin RJ; Perlmutter JS
Mov Disord; 2021 Apr; 36(4):948-954. PubMed ID: 33253432
[TBL] [Abstract][Full Text] [Related]
30. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
Wenning GK; Colosimo C
Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
[TBL] [Abstract][Full Text] [Related]
32. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
Sjöström H; Granberg T; Westman E; Svenningsson P
Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
[TBL] [Abstract][Full Text] [Related]
33. Extrastriatal
Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
[TBL] [Abstract][Full Text] [Related]
34. Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
Jiang C; Hopfner F; Katsikoudi A; Hein R; Catli C; Evetts S; Huang Y; Wang H; Ryder JW; Kuhlenbaeumer G; Deuschl G; Padovani A; Berg D; Borroni B; Hu MT; Davis JJ; Tofaris GK
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):720-729. PubMed ID: 32273329
[TBL] [Abstract][Full Text] [Related]
35. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
[TBL] [Abstract][Full Text] [Related]
36. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
[TBL] [Abstract][Full Text] [Related]
37. The circadian system in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Fifel K; De Boer T
Handb Clin Neurol; 2021; 179():301-313. PubMed ID: 34225971
[TBL] [Abstract][Full Text] [Related]
38. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic criteria of parkinsonian syndromes].
Tison F
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
[TBL] [Abstract][Full Text] [Related]
40. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
